View Cart (0 items)

Pharmaceutical

FDA bans import of drugs from Sun Pharma's Gujarat facility

The U.S. FDA has issued an import alert for Indian drug maker Sun Pharmaceuticals Ltd., banning the import of drug products manufactured at the company's facility in Gujarat.
Read More

Indian pharmaceutical firms braced for effect from US drug supply market mergers

The U.S. pharmaceutical supply chain is predicted to go through a stage of consolidation which will have an impact on the Indian drug manufacturing market, according to industry experts.
Read More

US, Indian officials meet to discuss drug safety

India and the United States have been locked in a regulatory conflict over generic pharmaceutical products distributed on the U.S. market.
Read More

Mexico's Neolpharma opens R&D facility in Puerto Rico

The Center for the Development and Innovation of Pharmaceutical Products, or Cediprof, will focus on research and experimentation of generic drugs.
Read More

Another Ranbaxy facility lands on FDA blacklist

The U.S. Food and Drug Administration (FDA) has added Ranbaxy's Toansa plant to the list of Indian facilities included on the consent decree dated January 2012.
Read More

Israel's Teva to buy NuPathe for $144 million

Pennsylvania-based NuPathe specializes in therapeutics for diseases of the central nervous system (CNS), including neurological and psychiatric disorders.
Read More

US, European watchdogs join forces to regulate generic drugs

The European Medicines Agency and the U.S. Food and Drug Administration have started a joint program for sharing information on bioequivalence studies required during the process of approval for generic drugs.
Read More

Global spending on medicines to grow by up to 6% per year through 2017

The key factors that will drive global drug markets are better access to medicines due to rising disposable income in developing countries and more favorable economic conditions in emerging markets.
Read More

FDA imposes new ban on Wockhardt drugs

Indian generic drug maker Wockhardt has been hit by a U.S. import alert for the second time this year.
Read More

Chinese anti-trust authorities launch probe into Bayer

German pharmaceutical giant Bayer AG is being investigated by Chinese authorities for unfair competition, becoming the latest foreign drug maker to come under examination in the Asian country.
Read More